AKINWANDE AKINTOLA: Open Payments
NPI 1942265038 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 2 payments from 2 companies in 2025. Trend: 2023 $114 · 2024 $249 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
Products named: INGREZZA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
